Meihao Medical Group Co (HKSE:01947) EBIT: HK$-17.1 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01947 Meihao Medical Group Co Ltd HKSE:01947
48 GF Score
Price HK$0.57
GF Value HK$0.40
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Meihao Medical Group Co EBIT?

Meihao Medical Group Co HKSE:01947 -3.42% 48 EBIT is HK$-17.1 Mil as of Dec. 2025. GuruFocus rates HKSE:01947 with a GF Score™ of 48/100 and a GF Value™ of HK$0.40 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Meihao Medical Group Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$-8.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-17.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Meihao Medical Group Co's annualized ROC % for the quarter that ended in Dec. 2025 was -12.04%. Meihao Medical Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -29.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Meihao Medical Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -6.84%.

Meihao Medical Group Co  (HKSE:01947) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Meihao Medical Group Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-25.05256388055 * ( 1 - 43.194% )/( (108.49115204801 + 127.86028956162)/ 2 )
=-14.231359437985/118.17572080481
=-12.04 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=202.23212616007 - 37.589728560463 - ( 80.001967762194 - max(0, 50.290175144791 - 106.44142069639+80.001967762194))
=108.49115204801

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=201.21719997424 - 13.515020284339 - ( 100.51615341686 - max(0, 51.811290470296 - 111.65318059858+100.51615341686))
=127.86028956162

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Meihao Medical Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-16.246287711386/( ( (59.472883957854 + max(-15.095268997278, 0)) + (50.031415539163 + max(-36.907344003778, 0)) )/ 2 )
=-16.246287711386/( ( 59.472883957854 + 50.031415539163 )/ 2 )
=-16.246287711386/54.752149748509
=-29.67 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.1272974670295 + 2.9842160351685 + 22.327939432001) - (37.589728560463 + 3.9449933710139 + -1.4210854715202E-14)
=-15.095268997278

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.91221374755837 + 3.2690443822757 + 6.955769051895) - (13.515020284339 + 16.121345277362 + 18.408005623806)
=-36.907344003778

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Meihao Medical Group Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-17.147/250.826
=-6.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meihao Medical Group Co EBIT Related Terms

Meihao Medical Group Co EBIT Historical Data

* Premium members only.

The historical data trend for Meihao Medical Group Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meihao Medical Group Co EBIT Chart

Meihao Medical Group Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 55.83 48.94 -6.11 -30.93 -16.92

Meihao Medical Group Co Semi-Annual Data
Dec19 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial -3.91 -14.79 -16.14 -8.52 -8.12

HKSE:01947 vs HCA, THC, EHC: EBIT Comparison

For the Medical Care Facilities subindustry, Meihao Medical Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meihao Medical Group Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Meihao Medical Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Meihao Medical Group Co's EV-to-EBIT falls into.


HKSE:01947
48GF Score
Meihao Medical Group Co Ltd HKSE:01947
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meihao Medical Group Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-17.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$-17.1 Mil mean?
Meihao Medical Group Co (HKSE:01947) has a EBIT of HK$-17.1 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Meihao Medical Group Co.
Is Meihao Medical Group Co's EBIT too high?
Meihao Medical Group Co's current EBIT is HK$-17.1 Mil. Overall, Meihao Medical Group Co has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Meihao Medical Group Co's EBIT compare to HCA and THC?
Meihao Medical Group Co's EBIT of HK$-17.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Meihao Medical Group Co. Meihao Medical Group Co's current EBIT is HK$-17.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihao Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Meihao Medical Group Co (HKSE:01947) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.40, compared to a current price of HK$0.57 — trading 41.3% above its estimated fair value. The current EBIT is HK$-17.1 Mil. Meihao Medical Group Co's overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Meihao Medical Group Co (HKSE:01947), the current EBIT is HK$-17.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Meihao Medical Group Co (HKSE:01947) Overvalued in 2026?

Based on GuruFocus' analysis, Meihao Medical Group Co stock appears to be overvalued. The current stock price of HK$0.57 is trading 41.3% above its estimated GF Value™ of HK$0.40. GuruFocus considers Meihao Medical Group Co to be Significantly Overvalued.

Key valuation signals for HKSE:01947:

  • EBIT: HK$-17.1 Mil
  • GF Value™: HK$0.40 vs. price of HK$0.57 (41.3% above fair value)
  • GF Score™: 48/100 with 7 warning signs

No single metric tells the full story. See the HKSE:01947 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Meihao Medical Group Co Business Description

Address 197 Fuqian Street, Lucheng District, Zhejiang Province, Wenzhou, CHN
Meihao Medical Group Co Ltd is a dental service provider in Wenzhou. It offers services to individuals and covers principally four dental sectors: general dentistry, reparative dentistry, implant dentistry, orthodontics, and cosmetic dentistry. The company generates all of its revenue from Mainland China from dental services.
48GF Score

Get the complete analysis for HKSE:01947

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.57
Price
HK$0.40
GF Value